Why Is AEHR TEST SYS (AEHR) Stock Up Today?

AEHR Test Systems stock is up 4.68% at $100.03 on Thursday, driven by Oppenheimer initiating coverage with an Outperform rating and a $120 price target. The stock opened with a 1.0% gap down but climbed to a session high of $100.45 by midday, fueled by the analyst action and broader market momentum. The move follows a recent 22.1% price increase over the past eight sessions and comes amid a volatile intraday session with volume of 1.4 million shares, or half the 3-month average.

What Happened

Oppenheimer analysts cited AI-driven demand as a key factor in their positive outlook for Aehr Test Systems, positioning the stock as a beneficiary of the growing semiconductor testing sector. The rating initiation triggered immediate buying interest, with the stock recovering from an early session low of $90.19. The stock has traded between $18.70 and $147.40 over the past 52 weeks, and Thursday’s move brought it closer to the upper end of that range. The coverage from Oppenheimer is the fourth story in 36 hours highlighting the stock, with three distinct sources reinforcing the bullish sentiment. The stock’s intraday trajectory also reflected strong late-session buying, with the last trade at $100.00 before the close.

What The Data Shows

The stock has shown a sharp upward trend, rising from $80.81 to $98.66 in the last eight sessions. However, Aehr Test Systems remains unprofitable, with a trailing 12-month EPS of -0.23 and a revenue decline of 15.2% TTM. The company’s net margin is -14.3%, and its beta of 3.07 indicates high volatility. Recent insider transactions include 13 sales totaling $18.9 million in the last 90 days, with no insider buys reported. The stock also printed one 52-week low and nine 52-week highs on September 10, suggesting mixed sentiment from institutional and retail participants.

What To Watch

The stock is currently without an upcoming earnings report. Investors should monitor the breadth of analyst coverage and whether other firms follow Oppenheimer’s lead with positive ratings or price targets.